Cargando…
E4orf1 improves adipose tissue-specific metabolic risk factors and indicators of cognition function in a mouse model of Alzheimer’s disease
OBJECTIVE: Obesity, impaired glycemic control, and hepatic steatosis often coexist and are risk factors for developing dementia, and Alzheimer’s disease (AD). We hypothesized that a therapeutic agent that improves glycemic control and steatosis may attenuate obesity-associated progression of dementi...
Autores principales: | Khan, Md Shahjalal Hossain, Hefner, Marleigh, Reddy, Arubala, Dhurandhar, Nikhil V., Hegde, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423203/ https://www.ncbi.nlm.nih.gov/pubmed/37573386 http://dx.doi.org/10.1038/s41387-023-00242-6 |
Ejemplares similares
-
The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19
por: Shah, Harsh, et al.
Publicado: (2021) -
Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
por: Hefner, Marleigh, et al.
Publicado: (2021) -
Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer’s Disease
por: Khan, Md Shahjalal Hossain, et al.
Publicado: (2020) -
E4orf1 protein reduces the need for endogenous insulin
por: Peddibhotla, Swetha, et al.
Publicado: (2019) -
E4orf1 induction in adipose tissue promotes insulin-independent signaling in the adipocyte
por: Kusminski, Christine M., et al.
Publicado: (2015)